Monthly Archives: October 2015

BioMarin Received its Third Overweight in a Row

After Cowen & Co. and Piper Jaffray assigned an Overweight rating to BioMarin in the last month, the company received another Overweight, this time from J.P. Morgan. Analyst Cory Kasimov reiterated an Overweight rating on BioMarin (NASDAQ: BMRN) yesterday and